MAP3K21 and ovarian cancer: MLK4 has been shown to inhibit the activation of MAPK pathways (including p38, JNK, and ERK), negatively regulate MLK3 kinase activity, and act as a suppressor of cell invasion in ovarian cancer [11–13].